Anavasi secures $14.9M from NIH for SARS-CoV-2 assay

By staff writers

November 10, 2021 -- Anavasi Diagnostics has secured $14.9 million from the U.S. National Institutes of Health (NIH) to accelerate development of its AscencioDx assay for the detection of SARS-CoV-2 infection. The award is distributed under the NIH's Rapid Acceleration of Diagnostics (RADxSM) initiative.

AscencioDx is in clinical trials, and Anavasi expects to file an emergency use authorization (EUA) with the U.S. Food and Drug Administration soon, it said. The EUA will establish the effectiveness of the test in point-of-care settings such as physician offices, emergency rooms, urgent care clinics, mobile testing sites, and colleges and universities, according to Anavasi.

AscencioDx uses loop-mediated isothermal amplification molecular diagnostic chemistry developed at the University of Washington in Seattle to detect HIV viral variants, Anavasi said.

BARDA seeks proposals for at-home SARS-CoV-2 tests
The Biomedical Advanced Research and Development Authority (BARDA) is seeking proposals from researchers to develop at-home, over-the-counter tests for...
SARS-CoV-2 leads pandemic dance, says AACC speaker
Stop dancing around with SARS-CoV-2 and take charge of the ongoing tango between viral mutations and human immune response, urged Dr. Margaret Liu at...
Door-to-door COVID testing helps reach vulnerable communities
A COVID-19 testing strategy that sends community workers door to door based on a sampling method borrowed from machine learning appears to be a more effective...
COVID-19 tests attempt to prove at-home testing concept can work
More than a year into the pandemic, at-home COVID-19 testing remains stable, and the healthcare industry continues to develop new tests, according to...
NIH, BARDA award $98.35M in COVID-19 testing contracts
The U.S. National Institutes of Health (NIH), along with the Biomedical Advanced Research and Development Authority (BARDA), a U.S. federal health agency,...

Copyright © 2021

Last Updated bc 11/10/2021 1:51:17 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current